Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Gomeni

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Mathematical Biosciences|December 8, 2014
Population modelling of patient responses in antidepressant studies: a stochastic approachEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 19, 2013
A PCA approach to population analysis: with application to a Phase II depression trialEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
Psychiatry Research|April 22, 2025
A novel artificial intelligence-based methodology to predict non-specific response to treatmentClotilde Guidetti, Maurizio Fava, Paolo L Manfredi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2014
Continuous-time Markov modelling of flexible-dose depression trialsEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 21, 2023
A convolution-based in vitro-in vivo correlation model for methylphenidate hydrochloride delayed-release and extended-release capsulePawan Kumar Gupta, Bev Incledon, Jogarao V S Gobburu, et al.
Computer Methods and Programs in Biomedicine|July 19, 2011
Bayesian population approaches to the analysis of dose escalation studiesAlberto Russu, Giuseppe De Nicolao, Italo Poggesi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 7, 2010
Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patientsRoberto Bizzotto, Stefano Zamuner, Giuseppe De Nicolao, et al.
British Journal of Clinical Pharmacology|August 29, 2018
Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H<sub>4</sub> receptor inhibitor SENS-111 using a modified caloric test in healthy subjectsFrédéric Venail, Pierre Attali, Eric Wersinger, et al.
Clinical Pharmacology : Advances and Applications|October 16, 2020
Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR<sup>®</sup>) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and SimulationShamia Faison, Roberto Gomeni, Shannon Mendes, et al.
British Journal of Clinical Pharmacology|October 24, 2002
Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced cravingVincenzo Teneggi, Lisa Squassante, Laura Iavarone, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Mathematical Biosciences|December 8, 2014
Population modelling of patient responses in antidepressant studies: a stochastic approachEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 19, 2013
A PCA approach to population analysis: with application to a Phase II depression trialEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
Psychiatry Research|April 22, 2025
A novel artificial intelligence-based methodology to predict non-specific response to treatmentClotilde Guidetti, Maurizio Fava, Paolo L Manfredi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2014
Continuous-time Markov modelling of flexible-dose depression trialsEleonora Marostica, Alberto Russu, Roberto Gomeni, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 21, 2023
A convolution-based in vitro-in vivo correlation model for methylphenidate hydrochloride delayed-release and extended-release capsulePawan Kumar Gupta, Bev Incledon, Jogarao V S Gobburu, et al.
Computer Methods and Programs in Biomedicine|July 19, 2011
Bayesian population approaches to the analysis of dose escalation studiesAlberto Russu, Giuseppe De Nicolao, Italo Poggesi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 7, 2010
Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patientsRoberto Bizzotto, Stefano Zamuner, Giuseppe De Nicolao, et al.
British Journal of Clinical Pharmacology|August 29, 2018
Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H<sub>4</sub> receptor inhibitor SENS-111 using a modified caloric test in healthy subjectsFrédéric Venail, Pierre Attali, Eric Wersinger, et al.
Clinical Pharmacology : Advances and Applications|October 16, 2020
Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR<sup>®</sup>) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and SimulationShamia Faison, Roberto Gomeni, Shannon Mendes, et al.
British Journal of Clinical Pharmacology|October 24, 2002
Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced cravingVincenzo Teneggi, Lisa Squassante, Laura Iavarone, et al.
Pageof 8